Basic Information
Basic information for TRAM2-AS1-215-31aa
Peptide Name TRAM2-AS1-215-31aa
Genome Position chr6:52579581-52579609,52582863-52582926[+]
Species Human
Peptide Sequence MRDPEPELARLTPHGYKVAATAPGVLSFNTE
Peptide Length 31
Unique No (TRAM2-AS1-202-31aa,TRAM2-AS1-203-31aa,TRAM2-AS1-204-31aa,TRAM2-AS1-208-31aa,TRAM2-AS1-210-31aa,TRAM2-AS1-211-31aa,TRAM2-AS1-212-31aa,TRAM2-AS1-213-31aa,TRAM2-AS1-214-31aa)
Grand Average of Hydropathicity -0.429
Relative Molecular Mass 3909.35
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000225791;TRAM2-AS1
Transcript ID/Name ENST00000667019;TRAM2-AS1-215
Transcript Length 2527
Coding Ability 0.4092
DNA Sequence Corresponding to Peptide ATGAGAGACCCTGAGCCAGAACTAGCCAGGCTTACCCCTCATGGTTACAAAGTGGCTGCAACAGCTCCAGGTGTTCTATCCTTTAACACAGAA
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :